Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method for improving the reporting rate of clinical adverse drug reactions

A technology for adverse reactions and drugs, applied in the field of medical systems, can solve problems such as low reporting rates, and achieve the effects of reducing non-reporting, reducing the time limit of lesions, and improving the pass rate

Active Publication Date: 2018-04-06
吉林大学中日联谊医院
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The technical problem to be solved by the present invention: ADR reporting in the prior art is self-reporting, the reporting rate is low, the situation of non-reporting and omission is serious, the incidents of adverse reactions of patients are increasing year by year, and the incompatibility of drugs that cannot be effectively avoided Reasonably caused technical problems such as adverse drug reactions, the present invention provides a method for improving the reporting rate of clinical drug adverse drug reactions to solve this type of technical problems, used for ADR case data terminal processing and uploading drug compatibility, eliminating lesions Time limit and check images for determining ADR cases, so as to improve the yield rate of dexamethasone injection, vitamin C injection, calcium gluconate injection and loratadine tablets for ADR cases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for improving the reporting rate of clinical adverse drug reactions
  • A method for improving the reporting rate of clinical adverse drug reactions
  • A method for improving the reporting rate of clinical adverse drug reactions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0023] A method for improving the reporting rate of clinical adverse drug reactions, such as figure 1 As shown, the method includes the following steps,

[0024] Step 1. Determine the first-aid drugs and anti-allergic drugs used for ADR adverse drug reactions

[0025] First, the ADR exclusive central processor is connected to the hospital's internal LAN through the CAN bus, and the name of the drug is retrieved from the emergency drug and anti-allergic drug database.

[0026] Secondly, the clinical use data of emergency medicine and antiallergic medicine were retrieved from the case database,

[0027] Input the obtained specific data into the ADR medication situation analysis module again,

[0028] Finally, dexamethasone injection, vitamin C injection, calcium gluconate injection and loratadine tablets were obtained as monitoring drugs;

[0029] Step 2. Front-line doctors input the clinical use data of dexamethasone injection, vitamin C injection, calcium gluconate injectio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method used for increasing a reporting rate of adverse drug reactions of clinical drugs, and belongs to the technical field of medical systems. According to the method, an adverse drug reaction (ADR) case is monitored through reverse screening, and a data terminal used for the ADR case processes compatibility of uploaded drugs, eliminates a nidus time limit and determines a check image of the ADR case, so that the technical effect of improving the effect of dexamethasone injection, vitamin C injection, calcium gluconate injection and loratadine tablets for the ADR case is achieved, and the technical problems of ADR and the like caused by unreasonable drug compatibility of the clinical drugs are avoided; and by use of the method provided by the invention, the working efficiency can be improved, the ADR reporting work of medical personnel can be effectively guided and supervised, and the phenomena of non-reporting and underreporting are greatly reduced, so that the method is worthy of nationwide popularization.

Description

technical field [0001] The invention belongs to the technical field of medical systems, and in particular relates to a method for improving the reporting rate of clinical drug adverse reactions. Background technique [0002] Adverse drug reactions (ADR) is an important clinical problem. Adverse drug reactions refer to harmful and unrelated reactions that occur when normal doses of drugs are used to prevent, diagnose, treat diseases or regulate physiological functions. Almost all drugs can cause adverse reactions, but the degree and incidence of reactions different. With the increasing number of drugs, the incidence of adverse drug reactions is also increasing year by year. Adverse drug reactions can sometimes cause drug-induced diseases. Except for a few people who self-administer drugs, adverse drug reactions are mainly caused by doctors administering drugs, so some drug-induced diseases are also iatrogenic diseases. Although some adverse drug reactions are difficult to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G16H70/40
CPCG06F19/326G06F19/36
Inventor 于倩王华李忻严明兰郭鑫毕铁琳郭义明
Owner 吉林大学中日联谊医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products